Obesity Medicine 2026 - Clinical Application of the Joint (TOS/OMA/OAC) Obesity Pharmacologic Guidance Publication (Recorded)

This session will review the rationale for the development of pharmacologic guidance for clinicians in treatment of the disease of obesity. The faculty will describe the evolution of this guidance document highlighting its applicability and relevance for clinicians based on the exhaustive evidence review using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach.

CME/CE Expiration Date: 4/12/29

*The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation. 

Course summary
Available credit: 
  • 0.50 AMA PRA Category 1 Credit™
    The Obesity Medicine Association (OMA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    The Obesity Medicine Association designates this Enduring activity for a maximum of 0.50 AMA PRA Category 1 Credit™. Physicians should claim only the commensurate amount with the extent of their participation in the activity.
  • 0.50 Participation
Course opens: 
04/12/2026
Course expires: 
04/12/2029
Cost:
$12.50

Angela Golden, DNP, FNP-C, FAANP, FOMA, FTOS and Lydia Alexander, MD, MFOMA, DABOM, DABLM

Available Credit

  • 0.50 AMA PRA Category 1 Credit™
    The Obesity Medicine Association (OMA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    The Obesity Medicine Association designates this Enduring activity for a maximum of 0.50 AMA PRA Category 1 Credit™. Physicians should claim only the commensurate amount with the extent of their participation in the activity.
  • 0.50 Participation

Price

Cost:
$12.50
Please login or register to take this course.

Required Hardware/software

For best user experience we recommend using a computer to complete this course.